This brand name is authorized in Germany, Netherlands, United Kingdom
The drug IMAP contains one active pharmaceutical ingredient (API):
|
1
Fluspirilene
UNII C5QA4GLR9M - FLUSPIRILENE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AG01 | Fluspirilene | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AG Diphenylbutylpiperidine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut fĂźr Arzneimittel und Medizinprodukte | Identifier(s): 01440563, 01957697, 04985843, 06164866 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 210245 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 12125733, 13718452 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 2372 |
Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
